miltefosine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
cytostatic 1810 58066-85-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • impavido
  • miltefosine
  • hexadecylphosphocholine
  • hexadecylphosphorylcholine
  • miltefos
hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
  • Molecular weight: 407.58
  • Formula: C21H46NO4P
  • CLOGP: -2.38
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 0
  • TPSA: 58.59
  • ALOGS: -6.32
  • ROTB: 20
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
0.15 g O

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

miltefosine